Myriad Genetics (MYGN) EBT Margin Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -211.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 399.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 28.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -317.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 4,440.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 3,000.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 135.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -2.00 |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | 1,201.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,201.00 |
| Dec 31, 2025 | 2,506.00 |
| Sep 30, 2025 | 1,552.00 |
| Jun 30, 2025 | -14,516.00 |
| Mar 31, 2025 | 100.00 |
| Dec 31, 2024 | 849.00 |
| Sep 30, 2024 | -3,373.00 |
| Jun 30, 2024 | -1,558.00 |
| Mar 31, 2024 | 1,584.00 |
| Dec 31, 2023 | 1,496.00 |
| Sep 30, 2023 | 2,609.00 |
| Jun 30, 2023 | 1,045.00 |
| Mar 31, 2023 | 5,091.00 |
| Dec 31, 2022 | -2,346.00 |
| Sep 30, 2022 | -1,629.00 |
| Jun 30, 2022 | -641.00 |
| Mar 31, 2022 | -1,753.00 |
| Dec 31, 2021 | -2,871.00 |
| Sep 30, 2021 | 2,339.00 |
| Jun 30, 2021 | -1,129.00 |